Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$10.54 - $19.3 $8.43 Million - $15.4 Million
-800,000 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$12.79 - $17.1 $10.2 Million - $13.7 Million
800,000 New
800,000 $11.2 Million
Q2 2020

Aug 14, 2020

SELL
$12.19 - $22.96 $13.7 Million - $25.8 Million
-1,124,879 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$10.08 - $27.21 $404,117 - $1.09 Million
-40,091 Reduced 3.44%
1,124,879 $17.5 Million
Q4 2019

Feb 14, 2020

BUY
$13.05 - $21.88 $8.68 Million - $14.5 Million
664,970 Added 132.99%
1,164,970 $23.5 Million
Q3 2019

Nov 14, 2019

BUY
$14.12 - $23.44 $7.06 Million - $11.7 Million
500,000 New
500,000 $7.06 Million
Q3 2018

Nov 14, 2018

SELL
$26.95 - $52.7 $5.39 Million - $10.5 Million
-200,000 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$28.08 - $31.2 $5.62 Million - $6.24 Million
200,000 New
200,000 $5.71 Million

Others Institutions Holding AVRO

# of Institutions
1
Shares Held
559K
Call Options Held
0
Put Options Held
0

About AVROBIO, Inc.


  • Ticker AVRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,773,900
  • Description
  • AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...
More about AVRO
Track This Portfolio

Track Deerfield Management Company, L.P. (Series C) Portfolio

Follow Deerfield Management Company, L.P. (Series C) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.